Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Rafael Holdings reports Q2 fiscal 2025 results; merger with Cyclo Therapeutics set to close in Q3 pending approvals.

Unusual Whales

Mar 13, 2025 at 10:12 PM

The merger with Cyclo Therapeutics is expected to be completed in the third quarter, subject to approval from shareholders.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Cyclo Therapeutics

CYTH.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--

LongbridgeAI